Sign in
8-K/A

Current Report

Taysha Gene Therapies, Inc. Filed Acc 0001193125-23-003537

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading d410825d8ka.htm…